GLP-1 and Macro-Nutrient Balance for Optimal Weight Loss
Introduction
Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide and tirzepatide, are increasingly prescribed for people living with obesity and type 2 diabetes. These medications operate by enhancing insulin secretion in response to food intake, reducing appetite, and effectively reducing body weight. However, by inducing caloric restriction and altering gastrointestinal physiology, GLP-1RAs may predispose patients to nutritional deficiencies.Importance of Macro-Nutrient Balance During GLP-1 Therapy
Achieving a balance of macronutrients, including carbohydrates, fats, and protein, is essential during GLP-1 therapy. This balance can help maintain consistent energy levels, aid in maintaining a healthier body weight, and ensure adequate nutrition. Consuming a gram of protein per kilogram of ideal body weight can prevent lean body mass loss and support muscle maintenance.Recommended Macronutrient Ratios
- Protein: 25-30% of daily caloric intake, crucial for muscle maintenance and repair
- Carbohydrates: 55-60% of daily caloric intake, essential for energy production and fiber intake
- Fats: 15-20% of daily caloric intake, important for satiety and overall nutrition
